Quantum Biopharma (QNTM) Long-Term Debt Issuances (2024 - 2026)

Quantum Biopharma's Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Long-Term Debt Issuances rose 2.46% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.2 million (down 9.25% YoY), while the FY2025 annual figure was $2.1 million, up 583.64% from the prior year.
• Long-Term Debt Issuances came in at $2.7 million for Q1 2026 at Quantum Biopharma, up from -$31372.0 in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $2.7 million in Q1 2026 to a low of -$1.7 million in Q4 2024.
• A 3-year average of $572848.1 and a median of $34308.0 in 2025 frame the typical range for Long-Term Debt Issuances.
• On a YoY basis, Long-Term Debt Issuances climbed as much as 363.54% in 2025 and fell as far as 104.29% in 2025.
• Quantum Biopharma's Long-Term Debt Issuances stood at -$1.7 million in 2024, then jumped by 98.13% to -$31372.0 in 2025, then soared by 8811.94% to $2.7 million in 2026.
• According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $2.7 million, -$31372.0, and $34308.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison